Strattera and Initial insomnia - a phase IV clinical study of FDA data

Summary:

Initial insomnia is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Adderall, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Initial insomnia when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,317 Strattera users. Check the latest studies of Strattera.

What is Initial insomnia?

Initial insomnia (feeling of inadequate or poor-quality sleep) is found to be associated with 812 drugs and 675 conditions by eHealthMe. Check the latest studies of Initial insomnia.

On Nov, 03, 2025

27,428 people reported to have side effects when taking Strattera.
Among them, 95 people (0.35%) have Initial insomnia.

Among these 95 people:

How long have people been on Strattera when they have Initial insomnia? *

What is the gender of people who have Initial insomnia when taking Strattera? *

female: 35.48 %
male: 64.52 %

What is the age of people who have Initial insomnia when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Initial insomnia? *

Drowsiness: 29 people, 30.53%
Fatigue (feeling of tiredness): 19 people, 20.00%
Drug Ineffective: 13 people, 13.68%
Headache (pain in head): 12 people, 12.63%
Nausea (feeling of having an urge to vomit): 12 people, 12.63%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 11 people, 11.58%
Psychomotor Hyperactivity (feelings of extreme restlessness): 11 people, 11.58%
Feeling Abnormal: 11 people, 11.58%
Mood Swings (an extreme or rapid change in mood): 10 people, 10.53%
Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 9 people, 9.47%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 7 people, 7.37%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 6.32%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 4.21%
Psychotic Disorder: 3 people, 3.16%
Failure To Thrive (inadequate weight gain and physical growth in children): 2 people, 2.11%
Circadian Rhythm Sleep Disorder (family of sleep disorders affecting, among other things, the timing of sleep): 2 people, 2.11%
Psychomotor Hyperactivity (feelings of extreme restlessness): 2 people, 2.11%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 2.11%
Apathy: 1 person, 1.05%
Asthma: 1 person, 1.05%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Initial insomnia?

- Check whether Initial insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,317 reports)

Initial insomnia treatments and more:

Initial insomnia (12,139 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Initial insomnia:

Initial insomnia (812 drugs)

Browse all the conditions that are associated with Initial insomnia:

Initial insomnia (675 conditions)

Drugs similar to Strattera and Initial insomnia :

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.